13 December 2021 | News
Aims to drive organic and inorganic growth in India and overseas
Image Credit: Shutterstock
Hyderabad-based NephroPlus has closed Series E round of funding to pursue growth opportunities across India and select international markets. The current round led by IIFL Asset Management (IIFL AMC) along with investment from existing investors InvestCorp and Bessemer Venture Partners (BVP) comes on the heels of notable scale-up that the company has delivered in recent years towards maintaining its dominant market leadership in the dialysis space.
Vikram Vuppala, Founder and CEO, NephroPlus, “We look forward to not only driving organic and inorganic growth in India and overseas with this capital, but also investing in building a unique digital health solution targeted at dialysis patients.”
So far, NephroPlus has signed up 200+ reputed hospitals as partners for operating dialysis centres including Fortis Hospitals, CARE Hospitals, Medanta and Max Healthcare. It has also set up PPP centres in partnership with state governments and operates the country’s largest dialysis centre at Tirupati.